Teleflex, a medical technology company, announced that it has completed its takeover of the vascular intervention activities Biotronik.
In February Teleflex concluded a final agreement with Biotronik to acquire its vascular intervention company for $ 895 million (€ 760 million).
The range of Teleflex includes vascular and interventional access, surgical, anesthesia, heart care, urology, emergency medicine and respiratory care.
Biotronic‘S Vascular activities include products for coronary and peripheral interventions, which are carried out in the Cath Lab and interventional radiology suits.
The product line comprises a ballon catheter, a coronary stent-covered by drugs, for acute coronary vein perforations and a drug-eluent stent covered by papyrus.
Televlex Said that the acquisition will enable it to invest in and his clinical test program for Freesolve, a Sirolimus-eluishing resorbable metallic scaffold, with plans to start an American study.
“We are pleased to announce the completion of the acquisition of almost all vascular intervention companies Biotronik earlier than expected, “said Liam Kelly, chairman, president and CEO of Teleflex, in a statement.
“The acquisition will significantly improve our worldwide presence in the Cath Lab, expand our series of innovative technologies and improve patient care.”
The larger trend
In April, Teleflex received extensive FDA 510 (K) statement of the Quikclot Control+ Hemostatic device from the company with indications of all figures from internal and external bleeding.
The device was previously indicated for temporary control of class III and class IV internal organ space bleeding, seriously bleeding surgical wounds, mild and moderate bleeding in heart surgical procedures and bone surfaces after sternotomy.
In January Teleflex received a contract Compare to deliver its central venous access catheters and arterial catheters to the company’s provider customers.
In February Biotronik collaborated with EGG Medical to co-sell eggs medically the egg package radiation protection systems for health workers in the US.
The Eggnest Systems (Eggnest XR, Cucnest Protect and Cucnest Complete) are radiation protection platforms that can be used on different types of fluoroscopy procedures without influencing the workflow.
According to the company, radiation reductions of up to 97% are possible with Eggnest XR and Eggnest Protect and up to 99% reductions are possible with Cucnest complete.
#Teleflex #completes #acquisition #Biotronik